Oncoinvent ASA Logo

Oncoinvent ASA

OSL-ONCIN
Oslo Børs NYSE
Healthcare Biological Products, Except Diagnostic Substances
Global Rank
#35692
Country Rank
n/a
Market Cap
20.48 M
Price
0.21
Change (%)
0.00%
Volume
0

Oncoinvent ASA's latest marketcap:

20.48 M

As of 05/31/2025, Oncoinvent ASA's market capitalization has reached $20.48 M. According to our data, Oncoinvent ASA is the 35692th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 20.48 M
Revenue (ttm) 793,283.7
Net Income (ttm) -13,725,677.9
Shares Out 97.74 M
EPS (ttm) -0.15
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/27/2025
Market Cap Chart
Data Updated: 05/31/2025

Oncoinvent ASA's yearly market capitalization.

Oncoinvent ASA has seen its market value drop from kr312.7 M to kr208.68 M since 2024, representing a total decrease of 33.27% and an annual compound decline rate (CAGR) of 61.44%.
Date Market Cap Change (%)
06/03/2025 kr208.68 M -33.27%
12/30/2024 kr312.7 M

Company Profile

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer.

Its lead product candidate is Radspherin, alpha-radiation therapy candidate designed for the direct targeting of cancers that have spread to body cavities, like the peritoneum in two phase 1/2a trials and one randomized phase 2 trial.

The company was incorporated in 2010 and is based in Oslo, Norway.

Frequently Asked Questions

  • What is Oncoinvent ASA's (OSL-ONCIN) current market cap?
    As of 05/31/2025, Oncoinvent ASA (including the parent company, if applicable) has an estimated market capitalization of $20.48 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Oncoinvent ASA global market capitalization ranking is approximately 35692 as of 05/31/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.